Search clinical trials for: Qvanteq bioactive coronary stent

Total 290 results

Qvanteq AG
Cardialysis BV

Completed

Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

Coronary Artery Disease

Netherlands, Switzerland
Brighton and Sussex University Hospitals NHS Trust
Abbott Medical Devices

Completed

Xience or Vision Stent Management of Angina in the Elderly (XIMA)

Coronary Artery Disease

United Kingdom
Micell Technologies
Yale Cardiovascular Research Group; North American Science Associates Inc.; Baim...

Not yet recruiting

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (CRYSTAL)

Coronary Artery Disease
Medinol Ltd.

Completed

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Ischemic Heart Disease

Israel, Sweden, Belgium, Germany
Odense University Hospital

Completed

The SOURT OUT IV TRIAL (SORT OUT IV)

Ischemic Heart Disease | Percutaneous Coronary Intervention | Coronary Atherosclerosis

Denmark
Abbott Medical Devices

Completed

The TRIMAXX Coronary Stent Trial

Coronary Artery Disease

Brazil, Germany
A.O. Ospedale Papa Giovanni XXIII
Medtronic; Case Western Reserve University

Completed

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography (OCTAMI)

Acute Myocardial Infarction

Italy
Palmaz Scientific
ClinLogix. LLC

Completed

Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study

Ischemic Heart Disease
CCRF Consulting Co., Ltd.
Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.

Unknown

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

Free Rate of Cardiac or Cerebrovascular Events | Transradial-transfemoral Coronary Interventions Comparison

China
BioSync Scientific Pvt. Ltd.
Cardialysis BV; MIV Therapeutics Inc.

Unknown

Hydroxyapatite Active Pro Healing Clinical Trial Program (HApFIM)

Coronary Artery Disease
Rigshospitalet, Denmark

Completed

DANish Multicenter STENT Trial

Ischemic Heart Disease | Stable Angina | Unstable Angina

Denmark
NHS National Waiting Times Centre Board

Completed

Glasgow Natural History Study Of Covered Coronary Interventions (GNOCCI)

Stent Thrombosis | Coronary Stent Occlusion | Coronary Artery Perforation

United Kingdom
OrbusNeich

Completed

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Coronary Artery Disease | Coronary Artery Stenosis

Netherlands, Belgium, United Kingdom, France, Germany, Austria
Hospital Sao Lucas da PUCRS

Completed

Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand (Tsunami)

Coronary Heart Disease | Atherosclerotic Heart Disease
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Bursa Postgraduate Hospital

Completed

Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries

Coronary Artery Ectasia
Medtronic Bakken Research Center

Completed

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (eFive)

Coronary Artery Disease
Abbott Medical Devices

Completed

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Myocardial Ischemia | Coronary Artery Disease | Vascular Disease | Coronary Artery Stenosis | Everolimus

Netherlands, Germany, Denmark
424 General Military Hospital

Completed

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention (IRICARDIO)

Myocardial Infarction | Coronary Artery Disease

Greece
Tryton Medical, Inc.

Unknown

eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries (eTRYTONLM)

Left Main Coronary Artery Stenosis

Germany
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Royal Brompton & Harefield NHS Foundation Trust

Completed

A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents (ORCA-2)

Coronary Artery Disease

United Kingdom
Stentys

Completed

STENTYS Self-expanding Versus Balloon-expandable Stent in Acute Myocardial Infarction (AMI) (APPOSITION ll)

STEMI

France
Montreal Heart Institute

Completed

Primary Reperfusion Secondary Stenting Trial (PRIMACY)

ST-elevation Myocardial Infarction

France, Canada
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Oslo University Hospital

Not yet recruiting

Myocardial Ischemia After Coronary Sinus Reduction Stent Implantation (MICS-Reduce)

Angina Pectoris
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (RENASCENT III)

Myocardial Ischemia | Coronary Artery Disease

Italy, Colombia
Amaranth Medical Inc.

Unknown

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (MEND II)

Myocardial Ischemia | Coronary Artery Disease

Colombia
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT II)

Myocardial Ischemia | Coronary Artery Disease

Colombia, Italy
Fundación Pública Andaluza Progreso y Salud

Unknown

Register of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía (RETRATO)

Unprotected Left Main Coronary Artery Stenosis

Spain
Boston Scientific Corporation

Unknown

A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion (PLATINUM China)

Coronary Artery Disease | Atherosclerosis

China
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT)

Myocardial Ischemia | Coronary Artery Disease

Italy
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Medtronic Bakken Research Center

Completed

Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain. (REDES)

Coronary Artery Disease

Spain
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Prof. Stephen Lee

Completed

OCT Evaluation of Early Healing of EPC Capturing (GENOUS) Stent (EGO Study) (EGO)

Coronary Artery Disease

Hong Kong
Biosensors Europe SA

Unknown

BioFreedom US IDE Feasibility Trial

Ischemic Heart Disease | Stable Angina | Unstable Angina | Silent Ischemia

United States
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
CeloNova BioSciences, Inc.
AlpinARC

Completed

Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry (eCOBRA)

Myocardial Infarction | Stable Angina | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

France
Helse Stavanger HF

Completed

Endothelial Function and Heart Rate Variability After Stenting (FUNKIS)

Restenosis or Adverse Cardiovascular Event

Norway
Biotronik AG

Completed

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions (BIOFLOW-I)

Coronary Artery Disease

Romania
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
InspireMD

Completed

The Israeli MGuard Registry

Acute Coronary Syndrome | Ischemic Heart Disease | Acute Myocardial Infarction

Israel
Azienda Ospedaliero Universitaria Maggiore della...

Completed

Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis

Myocardial Infarction | Restenosis

Italy
Atrium Medical Corporation

Terminated

COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1) (CONFIRM 1)

Coronary Artery Disease

Belgium
Micell Technologies
Cardialysis BV; ClinLogix. LLC

Unknown

Trial of MiStent Compared to Xience in Japan (DESSOLVEJ)

Coronary (Artery); Disease

Japan

Search clinical trials for: Qvanteq bioactive coronary stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations